News
In this personal essay, hairstylist and curl expert Kys Clark shares how having alopecia has redefined what beauty means to ...
Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...
"The launch of LEQSELVI in the U.S. brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them," said Richard Ascroft, CEO, ...
Sun Pharma and Incyte Corporation have settled a legal dispute over Leqselvi, a drug used for severe hair loss. Sun has ...
LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...
Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...
After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...
Actor Anthony Carrigan opened up to "Good Morning America" about his deeply personal connection to his "Superman" role.
A new study published in the Journal of American Medical Association showed that individuals with autoimmune skin diseases ...
Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results